Westbourne Investment Advisors, Inc. Abb Vie Inc. Transaction History

Westbourne Investment Advisors, Inc.

$272 Million
Q1 2024

A detailed history of Westbourne Investment Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Westbourne Investment Advisors, Inc. holds 7,600 shares of ABBV stock, worth $1.3 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

7,600

Previous 7,600 -0.0%

Holding current value

$1.3 Million

Previous $1.18 Million 17.49%

% of portfolio

0.51%

Previous 0.47%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $43,383 - $49,962	-300 Reduced 3.8%	7,600 $1.21 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $129,319 - $155,088	-935 Reduced 10.58%	7,900 $1.28 Million
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $13,421 - $15,393	-100 Reduced 1.12%	8,835 $1.19 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $4,128 - $5,248	-30 Reduced 0.33%	8,935 $1.37 Million
Q1 2022 Jun 15, 2022	SELL	$131.98 - $163.75 $69,289 - $85,968	-525 Reduced 5.53%	8,965 $1.45 Million

Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $10,743 - $13,593	-100 Reduced 1.04%	9,490 $1.29 Million
Q3 2021 Oct 25, 2021	SELL	$106.4 - $120.78 $3,724 - $4,227	-35 Reduced 0.36%	9,590 $1.03 Million
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $2,148 - $2,365	-21 Reduced 0.22%	9,625 $1.04 Million
Q4 2020 Jan 22, 2021	BUY	$80.49 - $108.67 $776,406 - $1.05 Million	9,646 New	9,646 $1.03 Million
Q2 2020 Jul 14, 2020	SELL	$73.37 - $98.18 $949,040 - $1.27 Million	-12,935 Closed	0 $0
Q4 2019 Jan 23, 2020	SELL	$72.13 - $90.25 $58,064 - $72,651	-805 Reduced 5.86%	12,935 $1.15 Million
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $24,247 - $29,152	-385 Reduced 2.73%	13,740 $1.04 Million
Q2 2019 Jul 22, 2019	SELL	$65.7 - $83.98 $51,903 - $66,344	-790 Reduced 5.3%	14,125 $1.03 Million
Q1 2019 Apr 15, 2019	SELL	$77.14 - $90.79 $6,556 - $7,717	-85 Reduced 0.57%	14,915 $1.2 Million
Q4 2018 Jan 18, 2019	SELL	$77.85 - $96.01 $15,569 - $19,202	-200 Reduced 1.32%	15,000 $1.38 Million
Q3 2018 Oct 18, 2018	BUY	$88.91 - $98.84 $256,505 - $285,153	2,885 Added 23.43%	15,200 $1.44 Million
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $49,379 - $58,426	-550 Reduced 4.28%	12,315 $1.14 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $103,971 - $139,227	-1,130 Reduced 8.07%	12,865 $1.22 Million
Q4 2017 Jan 31, 2018	SELL	$89.56 - $98.21 $67,170 - $73,657	-750 Reduced 5.09%	13,995 $1.35 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $1.03 Million - $1.32 Million	14,745	14,745 $1.31 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westbourne Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westbourne Investment Advisors, Inc. with notifications on news.

Account

Westbourne Investment Advisors, Inc. Abb Vie Inc. Transaction History